Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2016

Conditions

Cardiovascular Diseases

Interventions

DRUG

Estradiol+MPA

1 single pill dose daily containing estradiol 1 mg + medroxyprogesterone acetate 2.5 mg

DRUG

Estradiol+Drospirenone

1 single pill dose daily containing estradiol 1mg + drospirenone 0.5 mg

Trial Locations (1)

Brigham and Women's Hospital, Boston